Navigation Links
ADMIRE-HF Clinical Trial Published in the Journal of the American College of Cardiology
Date:5/17/2010

PRINCETON, N.J., May 17 /PRNewswire-FirstCall/ -- The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) trial, the results of which were published in the May 18th, 2010 issue of the Journal of the American College of Cardiology, is a prospective study evaluating cardiac sympathetic nerve imaging using Iobenguane I 123 Injection (AdreView™) for identifying symptomatic heart failure patients most likely to experience cardiac events.

According to the study, the drug imaging results produced a model with four independent variables contributing to the prediction of the primary outcome events.

"Increased cardiac sympathetic activity is a prominent feature of heart failure and is associated with progressive deterioration and remodeling of the myocardium, inexorable decline in left ventricular function, and worsening symptoms," said Professor Roxy Senior, MD, Director of Cardiac Research Northwick Park Hospital, an author of the study.  "Our results suggest that in appropriately selected patients with heart failure, the 123I-mIBG imaging procedure can alert clinicians to the potential need for considering additional treatments."  

About the ADMIRE-HF Trial

ADMIRE-HF consisted of two identical open-label phase III clinical studies evaluating the cardiac sympathetic nerves at the cellular level.  The studies were conducted in 96 centers in North America and Europe.  Nine hundred sixty-four patients with New York Heart Association (NYHA) Class II (83%) and III (17%) heart failure (66% ischemic, 34% non-ischemic) and left ventricular ejection fraction (LVEF) less than or equal to 35
'/>"/>

SOURCE GE Healthcare
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. ThromboGenics and BioInvent to Receive EUR10 Million Milestone as Partner Roche Begins New Clinical Study with TB-403
2. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
3. 3M and CitiusTech to Integrate 3M Healthcare Data Dictionary With CitiusTechs BI-Clinical Healthcare Business Intelligence Framework
4. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
5. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
6. Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes
7. Novocell Becomes ViaCyte, Inc., as it Accelerates Pre-Clinical Development of a Stem Cell Derived Treatment for Diabetes
8. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
9. US HIFU Receives Unanimous Approval to Continue the Clinical Investigation of High Intensity Focused Ultrasound (HIFU) for Treatment of Prostate Cancer
10. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2010 Financial Results
11. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... CARLSBAD, Calif. , May 20, 2013   ... today announced that its Applied Biosystems™ 3500 Dx and ... Federal Commission for Protection against Health Risks in ... marks a major extension of Life Technologies, capabilities to ... America with Sanger -based ...
(Date:5/20/2013)... May 20, 2013 Enrollment of patients with ... 2b dose-finding clinical trial of product candidate NewMet ... treatment for Type 2 diabetes. Elcelyx expects to complete ... in June. Results of the trial,s primary endpoint of ... summer, and the read-out for long-term glucose lowering and ...
(Date:5/20/2013)... , May 20, 2013  Medicare Part ... are overwhelmingly satisfied, citing lower costs, convenient access ... new survey from Hart Research Associates released today ... than 40% of Part D seniors (9.5 million) ... "Seniors like the lower costs, pharmacy ...
Breaking Medicine Technology:Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 2Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices 2
(Date:5/21/2013)... The National Resident Matching Program NRMP® ... its Board of Directors. Hal B. Jenson, M.D., ... of Medicine, has been named President. Maria C. ... of California San Diego, is the President-Designate, and Glenn ... Medical Center, is the Secretary-Treasurer. Kenneth B. Simons, ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 The Michigan ... meeting in Lapeer on , June 11th. , Meeting ... Location: Lapeer Regional Medical Center,     Conference Room 5 (Lower ... These meetings are designed to assist people with lupus ... one another, and to get a better understanding of ...
(Date:5/21/2013)... The birth control safety advocates at DrugRisk.com ... the contraceptive NuvaRing. A new report shows the number ... increased in recent months*. , DrugRisk was created to ... the latest safety alerts, recalls, studies and legal news. ... side effects and decide if they need legal advice. ...
(Date:5/20/2013)... (PRWEB) May 21, 2013 USA Book ... Transcendent Approach to Peak Performance" won the top honor ... Category. Chosen over a multitude of international titles ... attention and critical acclaim from both mainstream and new ... - mentally, physically and spiritually. , “The ...
(Date:5/20/2013)... Dallas, Texas (PRWEB) May 21, 2013 ... based on product type into two categories - ... AED market is classified into five categories, namely, ... the market is forecast till 2017. Automated external ... lives of sudden cardiac arrest victims. Considering the ...
Breaking Medicine News(10 mins):Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 2Health News:New Board of Directors Leadership for The Match- National Resident Matching Program® 3Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3
... 9, 2010, describes the discovery of an alternative form of ... sterilize them. Nematodes are among the most abundant, diverse and ... via Symbiosis; Recent Spread of a Drosophila Defensive ... and his colleagues. In a video interview, Jaenike explains the ...
... ... a range of preventable health problems, Sam’s Club is hosting free health screenings in more ... , ... July 8, 2010 -- To help its members and community residents detect a range of ...
... , THURSDAY, July 8 (HealthDay News) -- Scientists report they,ve ... "soldiers" in the immune system that might prevent the AIDS ... researchers, these newly found antibodies connect with and neutralize more ... all major genetic subtypes of the virus. That breadth ...
... provide authors additional time to complete their research, the ... 31 for the Cell Symposia meeting, Influenza: Translating basic ... Marriott Hotel in Washington, DC., Abstracts are invited for ... "Virus biology," "Pandemics, pathogenesis and disease," "Immune response and ...
... . Montreal, July 8, 2010 - A team of ... Cancer (IRIC) of the University of Montreal have identified ... IRIC Principal Investigators Martine Raymond, Alain Verreault and Pierre ... Research Institute of the National Research Council Canada, the ...
... NC Men who have a baseline PSA value of ... up to 11 times more likely to die from prostate ... to Duke University Medical Center researchers. Scientists say ... , supports routine, early prostate-specific antigen (PSA) screening among healthy ...
Cached Medicine News:Health News:Sam's Club Hosts Health Screenings July 10 2Health News:New Anti-HIV Weapons Found in Immune System 2Health News:Cell symposia meeting, Influenza: Translating basic insights, to be held Dec. 2-4, 2010 2Health News:Vitamin B3 as a novel approach to treat fungal infections 2Health News:Baseline PSA predicts risk of death from prostate cancer 2
IR Autoflow Dual Chamber Over-Under Water-Jacketed CO 2 Inc....
... The Dual Media Set, different from ... Broth (LB) or other specially prepared medium, ... OVEREXPRESSION BROTH (OB). For cell expansion, E. ... the production of the recombinant protein is ...
...
0.3% Beef extract, 0.5% Peptone, 0.5 % Lactose....
Medicine Products: